OliX Pharmaceuticals Advances RNAi Approaches to Target Highly Conserved Regions of Coronavirus RNAs
OliX has been developing novel delivery approaches for siRNAs to the lung tissue OliX’s local pulmonary administration of siRNA drugs through nebulization may contribute to improved treatment efficacy OliX’s previous research on idiopathic pulmonary …